Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Dist...

FDA Drug Recall #D-1153-2022 — Class II — June 3, 2022

Recall Summary

Recall Number D-1153-2022
Classification Class II — Moderate risk
Date Initiated June 3, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SUN PHARMACEUTICAL INDUSTRIES INC
Location Princeton, NJ
Product Type Drugs
Quantity 97,450 vials

Product Description

Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.

Reason for Recall

CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Lot / Code Information

HAC1974A, HAC1978A, Exp 06/2023

Other Recalls from SUN PHARMACEUTICAL INDUSTRIES INC

Recall # Classification Product Date
D-0342-2026 Class II Diclofenac Sodium, Topical Gel, 3%, 100 g tube,... Jan 27, 2026
D-0256-2026 Class III Fluocinolone Acetonide Solution Topical Solutio... Dec 30, 2025
D-0257-2026 Class III Clindamycin Phosphate USP, 1% (10 mg/mL), Topic... Nov 26, 2025
D-0149-2026 Class II Lisdexamfetamine Dimesylate Capsules, 60 mg, CI... Oct 28, 2025
D-0150-2026 Class II Lisdexamfetamine Dimesylate Capsules, 70 mg, CI... Oct 28, 2025

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.